Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Evolution of Medicare’s Merit-Based Incentive Payment System: MIPS Value Pathways

Ruth Jessen Hickman, MD  |  December 1, 2022

PHILADELPHIA—As part of an ACR Convergence Expert Roundtable on Sunday, Nov. 13, William Harvey, MD, MSc, associate professor of medicine at Tufts University, Boston, and chief medical informatics officer at Tufts Medicine, Boston, discussed a new iteration of Medicare’s Merit-Based Incentive Payment System (MIPS), the MIPS Value Pathways (MVPs). He shared how and why rheumatologists may want to implement it next year, potentially using the ACR’s Rheumatology Informatics System for Effectiveness (RISE) registry.

Dr. William Harvey

Dr. Harvey

In 2017, the Centers for Medicare & Medicaid Services (CMS) introduced MIPS as a part of its Quality Payment Program. MIPS was created as a way to pay clinicians partly based on the quality of their services and not just under a strict fee-for-services model. Under this model, final reimbursement was partly dependent on how well participants had met certain prespecified goals.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

MIPS Value Pathways

Beginning in 2023, physicians can opt to use MVPs rather than existing MIPS requirements to submit their information via MIPS.

MVPs were designed as an evolution of MIPS, Dr. Harvey explained. Using MVPs, clinicians can report on fewer measures and activities compared to those required by standard MIPS criteria. The idea is that reported measures would be more focused and meaningful in terms of specific specialties. MVPs were intended to “reduce complexity, remove clinician burden and foster a more cohesive patient experience,” Dr. Harvey reported. “That all sounds great, but as is often the case with the government, the devil is a bit in the details.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This November, the CMS finalized the 12 different MVPs in which clinicians can opt to participate, including the rheumatology MVP. “We made a conscious decision at the ACR that, rather than have somebody else dictate what measures are going to be relevant to us, we worked to build our own MIPS value pathway,” Dr. Harvey said. “This MIPS pathway was designed by the ACR and is supported by a lot of the things the ACR does, such as the RISE registry.”

Reporting with MVPs

MVPs retain the same four MIPS categories of reporting: Quality, Improvement Activities, Promoting Interoperability and Cost. Each category contains multiple measures, and physicians can choose which they will report.

For example, to meet the Quality category, four different measures must be selected, including at least one outcome measure. Examples include: meeting serum urate targets for gout, performing disease activity measurement in patients with psoriatic arthritis and assessing functional status in rheumatoid arthritis. Dr. Harvey noted that the reporting system has some flexibility; for example, if a physician reports more than four different Quality measures, the CMS will use the best four when calculating reimbursement.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsQuality Assurance/Improvement Tagged with:ACR Convergence 2022MIPSRISE registry

Related Articles

    2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published

    January 6, 2023

    The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

    Business Rheum: What to Expect from New MVP Measures

    December 1, 2021

    The new rheumatology-specific Merit-Based Incentive Payment System Value Pathway will focus on measures that most rheumatologists already track. The model should streamline reporting and better target quality improvements.

    2024 Proposed Rule for the Quality Payment Program Released

    August 17, 2023

    See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.

    Looking Forward to the Rheumatology MIPS Value Pathway

    October 25, 2021

    The field of rheumatology is leading the way in the Centers for Medicare and Medicaid Services’ new MIPS Value Pathways with rheumatology-specific quality measures and improvement activities.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences